248. グルコーストランスポーター1欠損症 Glucose transporter type 1 deficiency Clinical trials / Disease details
臨床試験数 : 29 / 薬物数 : 9 - (DrugBank : 1) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03202108 (ClinicalTrials.gov) | May 11, 2018 | 26/6/2017 | Evaluation of Krio in Children and Adults With Epilepsy | A Feasibility Study to Evaluate the Acceptability of Krio, a Food for Special Medical Purposes (FSMP) for Use in the Ketogenic Diet (KD) With Regard to Product Tolerance, Compliance and Acceptability | Ketogenic Dieting;Epilepsy;Glucose Transporter Type 1 Deficiency Syndrome | Dietary Supplement: Krio | Vitaflo International, Ltd | NULL | Withdrawn | 3 Years | N/A | All | 0 | N/A | United Kingdom |